NASDAQ:JNCE - Jounce Therapeutics Earnings Date, Estimates & History

+0.03 (+0.70 %)
(As of 07/16/2019 04:00 PM ET)
Today's Range
Now: $4.31
50-Day Range
MA: $4.59
52-Week Range
Now: $4.31
Volume68,400 shs
Average Volume184,558 shs
Market Capitalization$142.11 million
P/E RatioN/A
Dividend YieldN/A


Jounce Therapeutics (NASDAQ:JNCE) Earnings History and Estimates Chart

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Jounce Therapeutics (NASDAQ:JNCE) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.2 EPS
Next Year EPS Consensus Estimate: $-1.37 EPS

Jounce Therapeutics (NASDAQ JNCE) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/20193/31/2019($0.31)($0.38)($0.38)$14.75 million$10.98 millionViewN/AView Earnings Details
3/6/201912/31/2018($0.35)($0.06)($0.06)$12.86 million$20.10 millionViewListenView Earnings Details
11/13/2018Q3 2018($0.34)($0.23)($0.23)$12.80 million$14.53 millionViewN/AView Earnings Details
8/10/2018Q2 2018($0.37)($0.1440)($0.14)$12.47 million$19.38 millionViewN/AView Earnings Details
5/9/2018Q1 2018($0.31)($0.40)($0.40)$13.33 million$11.20 millionViewListenView Earnings Details
3/8/2018Q4 2017($0.59)($0.34)($0.39)$14.95 million$13.00 millionViewListenView Earnings Details
11/13/2017Q3 2017($0.25)($0.1270)($0.13)$20.00 million$18.10 millionViewN/AView Earnings Details
8/9/2017Q2 2017($0.15)($0.11)($0.11)$19.94 million$20.29 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.09)($0.02)($0.02)$19.71 million$20.30 millionViewN/AView Earnings Details
3/10/201712/31/2016$0.04$0.05$0.05$15.00 million$20.30 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 7/16/2019 by Staff

Featured Article: Coverage Ratio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel